News Sentiment

BMYS sentiment intelligence

Bristol-Myers Squibb Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 5 relevant articles
Exchange VIE Austria
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 50.17 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

68/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-0.3% over one week, +3.1% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Bristol Myers Squibb vs Pfizer Dividend Stock Comparison 2026 - News and Statistics

Market Reaction

Balanced read

44/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 68/100 classification
One-week reaction -0.3% Price digesting
Trend fit Trend active 3.1% over four weeks
Fair value 14.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
IndexBox 1
interpharma.ch 1
Finviz 1
Traders Union 1
Pharmaceutical Technology 1

Event Lens

What the news is about

Classified themes
Market update 3
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5